Neonatal Encephalopathy
48
12
16
18
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 48 trials
100.0%
+13.5% vs benchmark
4%
2 trials in Phase 3/4
28%
5 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (48)
Investigating Cerebral Oxygenation in the Newborn
Genetics of Neonatal Encephalopathy and Related Disorders
Assessment of Diastolic Function During the Transitional Period and Infancy Using Serial Echocardiography
Transcutaneous Carbon Dioxide Monitoring in Neonates Receiving Therapeutic Hypothermia for Neonatal Encephalopathy
Cooling in Mild Encephalopathy
Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
Telemedicine to Improve Use of Therapeutic Hypothermia in Rural Settings
Neonatal Neurologic Intensive Care Network of China
Nephroprotection Following Perinatal Asphyxia: Randomized Controlled Trial
Cell-Based Therapy for White Matter Repair in Periventricular Leukomalacia
Feasibility and Safety of Intranasally Administered Breast Milk in HIE
Dexmedetomidine Versus Morphine During Cooling Therapy in Neonates
Healthy Little Eyes
Natural History Study of Patients with HPDL Mutations
Neonatal Electrical Activity at Different Altitude Levels
Treatment of Neonatal Encephalopathy With Oral Sildenafil Suspension to Repair Brain Injury Secondary to Birth Asphyxia
Intranasal Breast Milk Therapy in HIE
Remote EEG Device for Identification of Risk for Neonatal Seizures